Shannon Thyme Klinger sold $486K of MRNA stock

Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc. (MRNA), sold 3,471 shares of MRNA stock worth $486K, per an SEC Form 4 filed Sep 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 1, 2026, 2 days before it was made public.

MRNA has moved +50.0% since the trade date, from $154.27 to $231.35 (Nov 12, 2026 close).